Loading clinical trials...
Loading clinical trials...
This study is planned as a part of the post market clinical follow-up (PMCF) on a CE marked product. The purpose of this study is to assess, in a routine clinical environment at two centers the use of fabian-PRICO with noninvasive ventilation and its safety and performance at targeting and maintaining accurate SpO2 levels.
This is a randomized cross-over study. Subjects will be assigned to two, nominally 12-hour interventions, one with standard manual titration of FiO2 and the other with automated adjustment (PRICO). The order of these two interventions will be random. In addition to the ventilators data, basic demographics (i.e., gestational age, birth weight, age, weight at study) of the participating infants will be recorded in the eCRF. This study has no additional follow-up visits.
Age
0 - 0 years
Sex
ALL
Healthy Volunteers
No
Buzzi Children's Hospital
Milan, Italy
Fondazione IRCCS San Gerardo dei Tintori
Monza, Italy
Start Date
June 1, 2023
Primary Completion Date
June 1, 2024
Completion Date
August 1, 2024
Last Updated
April 21, 2023
47
ESTIMATED participants
fabian Therapy evolution ventilators with PRICO (Predictive Intelligent Control of Oxygenation)
DEVICE
fabian Therapy evolution ventilators with manual FiO2 control
DEVICE
Lead Sponsor
Vyaire Medical
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions